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Ovulation is a highly regulated process, which involves the degradation and rupture of healthy tissue 
of the ovarian follicle and the extrusion of a fertilizable oocyte. This unique biological process is 
initiated by the LH-surge, which induces major vascular changes and remodelling of the extracellular 
matrix (ECM) in and around the follicle. The collagens of the ECM make up the tensile strength of the 
follicle wall and breakdown of these proteins seems to be a prerequisite for follicular rupture to occur. 
There is now robust evidence that matrix metalloproteinases (MMPs) and their endogenous tissue 
inhibitors (TIMPs) are crucial in this process. Earlier studies in this field have been mostly animal 
studies. 
The general aims of this thesis were to investigate the distribution of three types of collagens in the 
human ovary and to explore the expression patterns of the gelatinases, MMP-2 and MMP-9, together 
with their endogenous inhibitors, TIMP-2 and TIMP-1, during ovulation. 
The study was approved by the human Ethics Committee of Sahlgrenska Academy, Göteborg 
University. Informed written consent was obtained from all women participating in the study. 
Women, planned for laparoscopic sterilization participated in the study. They were closely monitored 
by transvaginal ultrasound. Surgery was performed during either of four distinct ovulatory phases and 
the dominant follicle and its adjacent stroma was excised. Granulosa and theca cells were harvested. 
Whole ovarian sections from premenopausal women undergoing oophorectomy at surgery for cervical 
cancer or due to familial predisposition to ovarian cancer were also obtained.  
The distribution of collagen types I, III and IV in biopsies of the perifollicular stroma from four 
distinct ovulatory phases as well as in whole ovarian sections was investigated by 
immunohistochemistry (paper I). Collagen types I and III were abundant in the perifollicular stroma 
around the periovulatory human follicle. These types of collagen were also present in a typical 
concentric layered pattern in the stromal capsule of the ovary making up a scaffold for the ovarian 
tissue. Collagen type IV was present in the basal lamina that separates the granulosa from the theca 
cells. The staining intensity of collagens type I and III in the perifollicular stroma decreased from 
preovulatory stage throughout ovulation indicating a degradation of the follicle wall. 
In paper II-IV, MMP-2, MMP-9 and TIMP-2 and TIMP-1 were found to be present in the stroma-, 
theca and granulosa cells compartment of the periovulatory follicle. The protein levels of these 
enzymes and inhibitors were examined by Western Blot in paper II. In paper II-IV mRNA expression 
was demonstrated by real time PCR and the protein distribution by immunohistochemistry. An 
increase of TIMP-1 was seen in the perifollicular stroma both on the protein- and mRNA- level. In the 
granulosa- and theca cells compartments a large increase in TIMP-1 and MMP-9 mRNA was 
demonstrated. Immunostaining for MMP-2, MMP-9, TIMP-2 and TIMP-1 was visualized in the 
different compartments of the periovulatory folllcle. 
In summary, the abundance of collagens in the human follicular wall and their specific localization 
suggest that major site-directed degradation of collagens is necessary for follicular rupture to occur. 
This is the first study that has demonstrated an ovulation-associated expression of the ECM 
remodelling enzyme, MMP-9, together with its endogenous inhibitor, TIMP-1, in and around the 
human follicle at ovulation. Increasing knowledge concerning these aspects of human ovulation could 
contribute to the development of clinical treatments of anovulation and also to the discovery of new 
contraceptive strategies that could inhibit ovulation on the ovarian level without the side effects of the 
oral contraceptives used today. 
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ACE  angiotensin converting enzyme  
ADAM  family proteins with a disintegrin-like and metalloprotease domain 
ADAMTS  family ADAM with trombospondin type I repeatsmembrane-type MMPs MT-MMPs 
Ang I  angiotensin I  
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CA  corpus albicans  
cDNA  complementary DNA  
CL  corpus luteum  
COX  cyclooxygenase  
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E2 oestradiol  
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EDN2 endothelin-2  
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ET  embryo transfer  
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IF  interferons  
IL  interleukins  
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LH  luteinising hormone  
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MCP-1 monocyte chemotactic protein-1  
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MMPs matrix metalloproteinases  
mRNA  messenger RNA 
NO nitric oxide  
NOS nitric oxide synthase  
NSAID  non-steroid-anti-inflammatory drug  
OD  optical density  
OSE ovarian surface epithelium  
P4 progesterone  
PA  plasminogen activator  
PAI-1, PAI-2 PA inhibitor-1 and -2  
PCOS  polycystic ovarian syndrome  
PCR  polymerase chain reaction  
PG  prostaglandins  
PKA  protein kinase A  
PMSG  pregnant mare’s gonadotropin  
PR  P4 receptor  
proMMP  precursor form of MMP  
PVDF  polyvinylidene fluoride  
RAS  renin-angiotensin system  
RNA  ribonucleic acid  
RT  reverse transcription  
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TA  tunica albuginea  
TE theca externa  
TGF-β transforming growth factor-β  
TI theca interna  
TIMPs  tissue inhibitor of  metalloproteinases  
TNF  tumor necrosis factor  
tPA  tissue-type PA  
TVU  transvaginal ultrasound  
uPA  urokinase-type PA  
VEGF  vascular endothelial growth factor  
 
